Tonix Pharmaceuticals Holding (TNXP) EBT Margin (QoQ) (2022 - 2026)

Tonix Pharmaceuticals Holding (TNXP) EBT Margin (QoQ) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,981.90 Bn 66,981.62 Bn -
2 Nanobiotix 1,913.50 Bn 1,913.44 Bn -
3 Akari Therapeutics 959.56 Bn 959.56 Bn -
4 BeOne Medicines 472.03 Bn 467.24 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.09 Bn 114.84 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.01 Bn 61.26 Bn 3.31 Bn
7 Belite Bio 62.34 Bn 62.34 Bn -
8 Argenx Se 55.99 Bn 50.80 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.49 Bn 34.48 Bn 959.66 Mn
10 Tonix Pharmaceuticals Holding 141.73 Mn 141.73 Mn 5.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 28,227.00
Dec 31, 2025 10,002.00
Sep 30, 2025 44,959.00
Jun 30, 2025 -76,879.00
Mar 31, 2025 22,379.00
Dec 31, 2024 -27,448.00
Sep 30, 2024 297,400.00
Jun 30, 2024 -264,059.00
Mar 31, 2024 -22,292.00
Dec 31, 2023 2,343.00
Sep 30, 2023 8,961.00
Sep 30, 2022 -29,166.00